Literature DB >> 12942236

Intravitreal triamcinolone for treatment of chronic focal immunological corneal graft reaction.

Jost B Jonas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942236     DOI: 10.1007/s00417-003-0719-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Transplantation and rejection of individual cell layers of the cornea.

Authors:  A A Khodadoust; A M Silverstein
Journal:  Invest Ophthalmol       Date:  1969-04

3.  Adjunctive intracameral application of corticosteroids in patients with endothelial immune reactions after penetrating keratoplasty: a pilot study.

Authors:  Thomas Reinhard; Rainer Sundmacher
Journal:  Transpl Int       Date:  2002-03-06       Impact factor: 3.782

4.  Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation.

Authors:  M S Blumenkranz; A Claflin; A S Hajek
Journal:  Arch Ophthalmol       Date:  1984-04

5.  Treatment of intraocular proliferations with intravitreal steroids.

Authors:  R Machemer; G Sugita; Y Tano
Journal:  Trans Am Ophthalmol Soc       Date:  1979
  5 in total
  2 in total

1.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

Review 2.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.